
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Guayusa leaf (Ilex guayusa) contains a unique combination of caffeine (29-75.7 mg/g), theobromine, and L-theanine that provides sustained energy without jitters by modulating dopamine, norepinephrine, and serotonin pathways. Its triterpenoids like ursolic acid activate membrane receptors to boost GLP-1 secretion, enhancing insulin sensitivity and glucose metabolism.

Reported Benefits (Provisional)
Origin & History

Guayusa Leaf (*Ilex guayusa*) is a species of holly tree native to the Amazon rainforest regions of Ecuador, Peru, and Colombia. Revered for its unique blend of stimulating compounds and antioxidants, it provides sustained energy and cognitive clarity without the jitters, making it a potent functional botanical.
Research Narrative (Provisional)
Scientific research, including studies published in peer-reviewed journals, validates Guayusa's cognitive-enhancing, antioxidant, and cardiovascular benefits. Investigations highlight the synergistic effects of its unique alkaloid and polyphenol profile in promoting sustained energy and mental clarity.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Alkaloids: Caffeine, Theobromine. - Amino Acids: L-theanine, L-arginine. - Phytochemicals: Chlorogenic acids, Polyphenols, Saponins. - Minerals: Potassium, Magnesium, Calcium.
Reported Mechanism (Provisional)
Guayusa's caffeine and theobromine provide stimulant effects while L-theanine modulates neurotransmitters including dopamine, norepinephrine, and serotonin to reduce jitteriness and enhance focus. Triterpenoids such as ursolic acid activate membrane receptors to stimulate incretin hormone (GLP-1) secretion, promoting insulin release and glucose uptake. Polyphenols including chlorogenic acid and catechins (epicatechin, EGCG) inhibit nitric oxide production and provide cellular antioxidant protection.
Clinical Narrative (Provisional)
Human clinical trials on guayusa are currently lacking, with most evidence coming from in vitro and animal studies. Laboratory research shows guayusa extracts provide 70-80% protection of Caco-2 cells from oxidative damage at 1 g/mL concentration and achieve 10-30% nitric oxide inhibition in cellular models. Comparative analyses suggest antioxidant potency exceeding green tea, though quantified human endpoint data for metabolic or cognitive outcomes are not yet available. The evidence base remains preliminary and requires dedicated human clinical trials.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







